Jeyakumar Kandasamy

Title: Innovations of Jeyakumar Kandasamy in Genetic Disorder Treatments

Introduction

Jeyakumar Kandasamy is a notable inventor based in Trichy, India. He has made significant contributions to the field of genetic disorder treatments through his innovative research and development. With a total of seven patents to his name, Kandasamy is recognized for his advancements in aminoglycosides.

Latest Patents

One of Kandasamy's latest patents focuses on a new class of pseudo-trisaccharide aminoglycosides. These compounds feature an alkyl group at the 5″ position, which exhibits efficient stop codon mutation readthrough activity. They are characterized by low cytotoxicity and high selectivity towards eukaryotic translation systems. The patent also includes pharmaceutical compositions containing these aminoglycosides and outlines their uses in treating genetic disorders. The aminoglycosides can be represented by a general formula, with specific variables and features detailed in the specification.

Career Highlights

Kandasamy is associated with the Technion Research & Development Foundation Limited, where he continues to push the boundaries of scientific research. His work has garnered attention for its potential impact on the treatment of genetic disorders.

Collaborations

Kandasamy collaborates with esteemed colleagues, including Timor Baasov and Dana Atia-Glikin. Their combined expertise enhances the research efforts and innovation in the field.

Conclusion

Jeyakumar Kandasamy's contributions to the field of genetic disorder treatments through his innovative aminoglycosides represent a significant advancement in medical science. His work continues to inspire future research and development in this critical area.